469 results on '"Reinert, R."'
Search Results
2. Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
Catalog
Books, media, physical & digital resources
3. Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997–2013)
4. Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals
5. Effect of acid rain and ozone on soil and secondary needle nutrients of loblolly pine
6. Immune Response to the 23-Valent Pneumococcal Polysaccharide Vaccine in Lymphoma Patients and Patients with Chronic Renal Diseases
7. STUDENTS PREFERENCES TOWARDS SUPPLEMENTARY LEARNING MATERIALS IN CLINICAL COURSES
8. Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany
9. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries
10. Streptokokken-Toxic-Shock-Syndrom (STSS) bei einer 23-jährigen Handballspielerin
11. Distribution of Four Capsular Serotypes of Enterococcus faecalis among Clinical Isolates from Different Geographical Origins and Infection Sites
12. Blood Culture Sampling Rates at a German Pediatric University Hospital and Incidence of Invasive Pneumococcal Disease
13. Distribution of emm types among group A streptococcal isolates from Serbia
14. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistantStreptococcus pneumoniae
15. Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age
16. The antimicrobial resistance profile of Streptococcus pneumoniae
17. The public health ramifications of pneumococcal resistance
18. Toxicity of Alkalinity to Hyalella azteca
19. Absorption of Dietary Dieldrin by Striped Bass
20. Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae
21. Staphylococcal scalded skin syndrome in an immunocompromised adult
22. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996–2002: results from a voluntary laboratory surveillance system
23. Risk factors for invasive group A streptococcal infections in Europe: O266
24. Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany
25. Recurrent bacteremia due toBrevibacterium casei in an immunocompromised patient
26. Biomonitoring ozone phytotoxicity in eastern Spain
27. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany
28. Recurrent systemic pneumococcal infection in an immunocompromised patient
29. Meningitis Due to Multiple-Resistant Penicillin- and Cefotaxime-Intermediate Streptococcus pneumoniae in a German Child after Bone Marrow Transplantation
30. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003
31. Sustained in vitro activity of telithromycin in Germany: the PROTEKT study (Years 1–4): P1787
32. Community-acquired pneumococcal pneumonia in Germany: first results of the CAPNETZ study: P1777
33. Characterisation of the first telithromycin resistant pneumococcal isolate in Germany: P1036
34. Characterisation of quinolone-resistant Streptococcus pneumoniae isolates in Germany: P1037
35. Changes in the global distribution of Streptococcus pneumoniae serotypes from paediatric isolates collected in PROTEKT Year 1 (Y1; 1999–2000) compared to Year 4 (Y4; 2002–2003): P1029
36. Phenotypic and genotypic characterisation of ‘atypical’ Streptococcus pneumoniae isolates by MLST: P632
37. Genetic characterisation of pneumococcal surface protein A: P614
38. Bacteremia caused byStomatococcus mucilaginosus: Report of seven cases and review of the literature
39. Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999–2000 and the in vitro efficacy of telithromycin and comparators
40. Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
41. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany
42. Resistance rates and resistance mechanisms of S. pneumoniae strains isolated from eight European countries: final report of the PNEUMOWORLD study
43. Susceptibility of Streptococcus pyogenes to telithromycin and erythromycin: results from PROTEKT (years 1–3)
44. Unchanged susceptibility of key respiratory pathogens to telithromycin postintroduction in Germany
45. Hospital outbreak of an imipenem-resistant VIM-2 encoding Acinetobacter DNA group 14 TU strain in a German teaching hospital
46. Characterization of S. pneumoniae and S. pyogenes strains isolated from the respiratory tract of pediatric outpatients in Germany, 2002
47. Telithromycin is highly active against Streptococcus pneumoniae isolates, including resistant strains, from pediatric patients: PROTEKT Year 1 vs. Year 2
48. Invasive pneumococci in the pediatric population of Germany: Epidemiology and coverage of the 7 valent pneumococcal conjugate vaccine, 1997–2001
49. Exploring Asteroid Interiors: The Deep Interior Mission Concept
50. Immune Response to the 23-Valent Pneumococcal Polysaccharide Vaccine in Lymphoma Patients and Patients with Chronic Renal Diseases
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.